Wire · opportunities
Abbott initiates VOYAGER clinical trial for investigational Encantor™ software-guided ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 20 November 2026 · Fusion42 review
Abbott has launched the VOYAGER CE clinical trial in Europe and Australia to evaluate the safety and efficacy of its investigational Encantor software-guided balloon-expandable TAVI system for treating severe aortic stenosis. The trial aims to support regulatory approval and provides a new tool for precise valve implantation tailored to patient anatomy.
This Wire brief sits within Fusion42's coverage of Medtech, and 3 sources have reported it between 19 Nov 2026 and 20 Nov 2026.
◆ ◆ The Wire takeaway
You now have a new software-driven TAVI system trialled in Europe and Australia that aims to improve procedural precision and patient outcomes. Prepare to engage with teams looking for software-enhanced valve implantation options as approvals progress.
◆ Coverage
3 sources · first reported 19 Nov 2026 · latest 20 Nov 2026
◆ Related on Wire
◆ Topics